Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease

Published:2019-12 Issue:12 Volume:30 Page:903-914
ISSN:1043-2760
Container-title:Trends in Endocrinology & Metabolism
language:en
Short-container-title:Trends in Endocrinology & Metabolism

Author:

Chen Ze,Yu Yao,Cai Jingjing,Li Hongliang

Funder

Hubei Science and Technology Support Project

Major Research Plan of the National Natural Science Foundation of China

National Science Fund for Distinguished Young Scholars

National Science Foundation of China

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference100 articles.

1. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

2. Triggering and resolution of inflammation in NASH;Schuster;Nat. Rev. Gastroenterol. Hepatol.,2018

3. Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?;Lonardo;J. Hepatol.,2018

4. Past, present and future perspectives in nonalcoholic fatty liver disease;Sanyal;Nat. Rev. Gastroenterol. Hepatol.,2019

5. Unexpected rapid increase in the burden of nonalcoholic fatty liver disease in China from 2008 to 2018: a systematic review and meta-analysis;Zhou;Hepatology,2019

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of epigallocatechin gallate in treating non-alcoholic fatty liver disease: Insights from network pharmacology and experimental validation;Biochemical and Biophysical Research Communications;2024-11

2. Machine learning based identification potential feature genes for prediction of drug efficacy in nonalcoholic steatohepatitis animal model;Lipids in Health and Disease;2024-08-24

3. CPS1 augments hepatic glucagon response through CaMKII/FOXO1 pathway;Frontiers in Pharmacology;2024-08-13

4. A novel peptide encoded by circ‐SLC9A6 promotes lipid dyshomeostasis through the regulation of H4K16ac‐mediated CD36 transcription in NAFLD;Clinical and Translational Medicine;2024-08

5. Pemafibrate abrogates SLD in a rat experimental dietary model, inducing a shift in fecal bile acids and microbiota composition;Biomedicine & Pharmacotherapy;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3